Clinical presentation and prognosis in MOG-antibody disease: a UK study M Jurynczyk, S Messina, MR Woodhall, N Raza, R Everett, ... Brain 140 (12), 3128-3138, 2017 | 673 | 2017 |
Neuromyelitis optica spectrum disorders with aquaporin-4 and myelin-oligodendrocyte glycoprotein antibodies: a comparative study J Kitley, P Waters, M Woodhall, MI Leite, A Murchison, J George, W Küker, ... JAMA neurology 71 (3), 276-283, 2014 | 628 | 2014 |
The social, economic, and environmental importance of inland fish and fisheries AJ Lynch, SJ Cooke, AM Deines, SD Bower, DB Bunnell, IG Cowx, ... Environmental reviews 24 (2), 115-121, 2016 | 502 | 2016 |
Myelin-oligodendrocyte glycoprotein antibodies in adults with a neuromyelitis optica phenotype J Kitley, M Woodhall, P Waters, MI Leite, E Devenney, J Craig, J Palace, ... Neurology 79 (12), 1273-1277, 2012 | 502 | 2012 |
Glycine receptor antibodies in PERM and related syndromes: characteristics, clinical features and outcomes A Carvajal-Gonzalez, MI Leite, P Waters, M Woodhall, E Coutinho, ... Brain 137 (8), 2178-2192, 2014 | 498 | 2014 |
Prognostic factors and disease course in aquaporin-4 antibody-positive patients with neuromyelitis optica spectrum disorder from the United Kingdom and Japan J Kitley, MI Leite, I Nakashima, P Waters, B McNeillis, R Brown, Y Takai, ... Brain 135 (6), 1834-1849, 2012 | 473 | 2012 |
MOG cell-based assay detects non-MS patients with inflammatory neurologic disease P Waters, M Woodhall, KC O'Connor, M Reindl, B Lang, DK Sato, ... Neuroimmunology & Neuroinflammation 2 (3), e89, 2015 | 389 | 2015 |
Multicentre comparison of a diagnostic assay: aquaporin-4 antibodies in neuromyelitis optica P Waters, M Reindl, A Saiz, K Schanda, F Tuller, V Kral, P Nytrova, ... Journal of Neurology, Neurosurgery & Psychiatry 87 (9), 1005-1015, 2016 | 257 | 2016 |
Serial anti–myelin oligodendrocyte glycoprotein antibody analyses and outcomes in children with demyelinating syndromes P Waters, G Fadda, M Woodhall, J O’Mahony, RA Brown, DA Castro, ... JAMA neurology 77 (1), 82-93, 2020 | 252 | 2020 |
Distinct brain imaging characteristics of autoantibody-mediated CNS conditions and multiple sclerosis M Jurynczyk, R Geraldes, F Probert, MR Woodhall, P Waters, G Tackley, ... Brain 140 (3), 617-627, 2017 | 241 | 2017 |
Antibodies to MOG in adults with inflammatory demyelinating disease of the CNS SM Kim, MR Woodhall, JS Kim, SJ Kim, KS Park, A Vincent, KW Lee, ... Neuroimmunology & Neuroinflammation 2 (6), e163, 2015 | 237 | 2015 |
Myelin oligodendrocyte glycoprotein antibodies are associated with a non-MS course in children Y Hacohen, M Absoud, K Deiva, C Hemingway, P Nytrova, M Woodhall, ... Neuroimmunology & Neuroinflammation 2 (2), e81, 2015 | 233 | 2015 |
Seizures and encephalitis in myelin oligodendrocyte glycoprotein IgG disease vs aquaporin 4 IgG disease SHM Hamid, D Whittam, M Saviour, A Alorainy, K Mutch, S Linaker, ... JAMA neurology 75 (1), 65-71, 2018 | 217 | 2018 |
EfeUOB (YcdNOB) is a tripartite, acid‐induced and CpxAR‐regulated, low‐pH Fe2+ transporter that is cryptic in Escherichia coli K‐12 but functional in E. coli O157: H7 J Cao, MR Woodhall, J Alvarez, ML Cartron, SC Andrews Molecular microbiology 65 (4), 857-875, 2007 | 216 | 2007 |
International multicenter examination of MOG antibody assays M Reindl, K Schanda, M Woodhall, F Tea, S Ramanathan, J Sagen, ... Neurology: Neuroimmunology & Neuroinflammation 7 (2), e674, 2020 | 212 | 2020 |
A multicenter comparison of MOG-IgG cell-based assays PJ Waters, L Komorowski, M Woodhall, S Lederer, M Majed, J Fryer, ... Neurology 92 (11), e1250-e1255, 2019 | 197 | 2019 |
Brain lesion distribution criteria distinguish MS from AQP4-antibody NMOSD and MOG-antibody disease M Juryńczyk, G Tackley, Y Kong, R Geraldes, L Matthews, M Woodhall, ... Journal of Neurology, Neurosurgery & Psychiatry 88 (2), 132-136, 2017 | 159 | 2017 |
Longitudinal analysis of myelin oligodendrocyte glycoprotein antibodies in CNS inflammatory diseases JW Hyun, MR Woodhall, SH Kim, IH Jeong, B Kong, G Kim, Y Kim, ... Journal of Neurology, Neurosurgery & Psychiatry 88 (10), 811-817, 2017 | 153 | 2017 |
Clinical features and diagnostic usefulness of antibodies to clustered acetylcholine receptors in the diagnosis of seronegative myasthenia gravis PMR Cruz, M Al-Hajjar, S Huda, L Jacobson, M Woodhall, S Jayawant, ... JAMA neurology 72 (6), 642-649, 2015 | 144 | 2015 |
Paraneoplastic neurologic disorders in small cell lung carcinoma: a prospective study P Gozzard, M Woodhall, C Chapman, A Nibber, P Waters, A Vincent, ... Neurology 85 (3), 235-239, 2015 | 124 | 2015 |